【Healthkoreanews】According to the IMS Health Data, Ildong's sales are top ranked in the Korean antiibiotic market.
In the first half of 2008, Ildong’s Flumarin(antibiotic) sales recorded 15.8 billion won, followed by Yuhan’s Meropen and Jeil’s Cravit (respectively 11.5 billion won and 9.9 billion won).
The top 10 antibiotics in the first half of 2008 are as follows.
1. Flumarin(Ildong)/15.8 billion won
2. Meropen(Hanmi)/11.5 "
3. Cravit(Jeil)/9.9 "
4. Triaxon(Hanmi)/7.8 "
5. Clari(Hanmi)/7.6 "
6. Augmentin(Ilsung)/7.6 "
7. Banan(CJ)/7.1 "
8. Refosporen(Hanall)/7.0 "
9. Tazocin(Wyeth)/6.6 "
10.Citopcin(CJ/6.4 "<헬스코리아뉴스>